JPRN-UMIN000015402尚未招募未知
Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetes - Effects of a SGLT2 inhibitor on glucose metabolism and body composition in patients with type 2 diabetes
Department of Diabetes and Endocrinology Kobe City Medical Center General Hospital0 个研究点目标入组 30 人开始时间: 2014年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 75years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1.Serious infection 2.Serious liver and/or kidney disease 3.End stage renal disease with undergoing hemodialysis or peritoneal dialysis
研究者
相似试验
进行中（未招募）
1 期
The effect of SGLT2 inhibitors on glucose and ketone productioEUCTR2015-002094-38-GBniversity of Leicester30
已完成
不适用
The Effect of SGLT2 inhibitors on blood glucose variability in patients with type 1 diabetestype 1 diabetes mellitusJPRN-UMIN000039361Hokkaido University Hospital30
进行中（未招募）
1 期
The effect of SGLT2 inhibitors in people with type 2 diabetesEUCTR2016-004878-17-GBniversity of Leicester18
已完成
不适用
Investigation of metabolic change by SGLT2 inhibitors in type 2 diabetes patients.JPRN-UMIN000015057Kitasato University School of Medicine,Endocrinology and Metabolism.20
已完成
不适用
Effect of SGLT2 inhibitor on energy metabolism in patients with type 2 diabetesType 2 diabetesJPRN-UMIN000024822Kyoto University Graduate School of Medicine100